Friday, July 13, 2012

Top 20 biotech licensing deals in H1 2012

Very nice collection from here.
 

Bristol-Myers Squibb and AstraZeneca
Galapagos NV and Abbott Laboratories
Endocyte and Merck
Forma Therapeutics and Boehringer Ingelheim
Forma Therapeutics and Janssen (Johnson & Johnson)
Xenon and Genentech
Threshold Pharmaceuticals and Merck KGaA
Celgene and Inhibrx
Thrombogenics and Merck KGaA
Enanta and Novartis
AC Immune and Genentech
Bionomics and Ironwood Pharmaceuticals
Virobay and Leo Pharma
Angiochem and GlaxoSmithKline
Isis Pharmaceuticals and Biogen Idec
Isis Pharmaceuticals and Biogen Idec, Take Two
FivePrime Therapeutics and GlaxoSmithKline
BioDelivery Sciences and Endo Pharmaceuticals
Genmab and Novartis
Mannkind Corp. and Tolero Pharmaceuticals

1 comment: